Tumour burden and efficacy of immune-checkpoint inhibitors.
Nat Rev Clin Oncol. 2022 Feb;19(2):75-90. doi: 10.1038/s41571-021-00564-3. Epub 2021 Oct 12.
Nat Rev Clin Oncol. 2022.
PMID: 34642484
Review.